CFIUS reviews foreign investments in U.S. entities for national security risks. The Committee on Foreign Investment in the United States evaluates deals across sectors, imposes conditions, or blocks transactions. Institutional investors must navigate sector-specific restrictions and disclosure requirements.
The Committee on Foreign Investment in the United States (CFIUS) has become a material constraint on portfolio construction for global asset owners. Since 2018, the Committee's definition of "critical infrastructure" and "critical technologies" has expanded substantially, capturing sectors from semiconductors to renewable energy. Asset owners with U.S.-listed equities or private equity positions in sensitive industries now face regulatory unpredictability that affects deal timing, valuation multiples, and cross-border capital deployment strategies.
What is CFIUS and why should institutional investors pay attention?
CFIUS is an interagency committee chaired by the Treasury Department, tasked with reviewing foreign acquisitions of U.S. businesses for national security concerns. Established in 1975 but substantially reformed under the Foreign Investment Risk Review Modernization Act (CFIRMA) in 2018, the Committee now screens investments not only in defense and critical infrastructure but in emerging technologies, semiconductors, telecommunications, and data infrastructure.
For asset owners, the practical impact is direct. A $2 billion cross-border acquisition that might have cleared in 2015 now faces months of review or outright rejection. The Committee issued 176 orders suspending or prohibiting investments in 2022, compared with 23 in 2012, according to filings available through the Treasury's CFIUS office. For pension funds, sovereign wealth funds, and endowments with significant U.S. equity exposure or international diversification mandates, this regulatory layer has become unavoidable.
How has CFIUS scope expanded since 2018?
The Foreign Investment Risk Review Modernization Act fundamentally rewired CFIUS's mandate. Prior to 2018, the Committee focused narrowly on controlling interests in defense contractors and critical infrastructure. CFIRMA lowered the threshold for committee review, expanded the definition of "critical infrastructure" to encompass energy systems, telecommunications networks, and transportation infrastructure, and introduced new triggers for "critical technology" acquisitions—even minority stakes.
Today, CFIUS screens investments in artificial intelligence, quantum computing, certain semiconductor fabrication nodes, rare earth processing, and biotechnology. The Committee also expanded its lens to include non-controlling investments: a foreign entity can now face CFIUS review by acquiring just 25 percent of a company in a critical sector, or even a smaller stake if it confers board representation or access to sensitive data.
This expansion has material consequences for allocation. CalPERS, the largest U.S. pension fund with $461.6 billion in assets under management as of mid-2024, reported in its international investment policy that CFIUS uncertainty has lengthened due diligence timelines on certain U.S.-based acquisition targets. The Committee's case-by-case assessment creates pricing pressure on deals involving Chinese, Russian, or government-affiliated investors, but also on deals from allied nations when critical technologies are involved.
What sectors face the highest CFIUS scrutiny?
Semiconductors and semiconductor manufacturing equipment represent the frontline of CFIUS review. Taiwan Semiconductor Manufacturing Company (TSMC) and Samsung's U.S. investments have undergone heightened scrutiny, though CFIUS has approved most of their capital-light operations. The Committee has, however, blocked or forced divestitures in foreign-backed semiconductor design and fabrication ventures.
Energy infrastructure, particularly renewable energy and grid-modernization technology, has attracted CFIUS attention in ways that parallel concerns about critical minerals and supply chain resilience. This aligns with Data Center Power Demand and the Grid, for Asset Owners, where foreign investment in power generation and distribution directly intersects with national security definitions.
Telecommunications networks, cloud infrastructure, and cybersecurity platforms face heightened review, particularly for companies handling sensitive data. Healthcare, biotechnology, and pharmaceuticals experience selective scrutiny, typically when foreign investment involves access to genetic databases or clinical trial data.
Financial data providers and credit rating agencies have also encountered CFIUS review, though approval rates remain high for transactions involving allied nations.
Which countries and investor types draw the most CFIUS attention?
CFIUS review patterns are geographically concentrated. Investments from China, Russia, Iran, and North Korea face presumptive heightened scrutiny. Sovereign wealth funds and government-affiliated investors from any country triggering CFIUS review require extended timelines and often face forced divestitures.
Norwegian sovereign wealth funds, Canadian pension funds, and Western European investors generally face faster clearance, though CFIUS maintains case-by-case discretion. Australian and Japanese investors typically experience minimal friction. The Committee has, however, blocked acquisitions from allied nations when critical technology transfer was at issue.
For emerging market asset owners, this creates a bifurcated opportunity set. Investors from Gulf Cooperation Council nations and India face moderate scrutiny; those from Southeast Asia face variable scrutiny depending on specific jurisdictions. Chinese state-owned enterprises and government-linked investors face consistent, prolonged review processes that often result in forced divestitures or outright prohibition.
How does CFIUS interact with broader foreign investment frameworks?
CFIUS operates within a expanding constellation of regulatory frameworks. The European Union's Foreign Direct Investment Screening Regulation, adopted in 2020, mirrors some CFIUS logic but applies EU-wide thresholds. The UK, post-Brexit, established the National Security and Investment Act, which screens foreign acquisitions on security grounds. Canada's Investment Canada Act includes national security review provisions that similarly have expanded post-2018.
Allied nations have progressively coordinated screening mechanisms. The Quad—the security partnership between the United States, Japan, India, and Australia—has informally aligned on certain technology-sector definitions, though no formal CFIUS equivalent exists outside the U.S. framework.
For global asset owners, this regulatory convergence means that a deal rejected by CFIUS may face parallel obstacles in European or other jurisdictions. Conversely, U.S.-domiciled investors face comparable constraints when investing in sensitive sectors abroad. Saudi Vision 2030 and the Investment Strategy Behind It illustrates how sovereign wealth funds navigate these constraints by prioritizing non-sensitive sectors or by structuring minority stakes that avoid CFIUS thresholds.
What are the practical compliance implications for allocators?
Asset owners conducting U.S. M&A or greenfield investments in critical sectors should budget 6 to 12 months for CFIUS review timelines, even for straightforward transactions. Deal documentation must explicitly address how the transaction avoids or manages CFIUS risk. Underwriting should include CFIUS-specific legal fees and assume potential delays.
For portfolio companies, CFIUS restrictions can cascade: a portfolio company that acquires a critical-technology firm may itself become subject to CFIUS review if the parent has foreign limited partners. This creates incentive structures that favor divesting sensitive assets or restructuring ownership to minimize foreign control.
International diversification strategies must account for reciprocal screening regimes. A European pension fund investing in U.S. semiconductors may face CFIUS delay; conversely, if that fund holds U.S.-domiciled investors, their U.S. commitments may face foreign screening constraints elsewhere. These frameworks are creating friction costs that affect return assumptions, particularly in technology-heavy portfolios.
Commodity and infrastructure investing—areas where The Commodity Supercycle and Institutional Investors and The Discount Rate and Pension Liabilities, Explained outline allocation strategies—are increasingly subject to foreign investment review when they involve critical minerals, energy infrastructure, or water resources deemed strategically important.
Implications for long-term capital allocation
CFIUS and analogous frameworks globally are crystallizing into a structural feature of capital markets. The regulatory tightening reflects genuine geopolitical fragmentation around technology and infrastructure, not temporary policy cycles. Asset owners should assume that CFIUS will remain expansive in scope and that allied-nation coordination will intensify.
Three practical shifts follow. First, expected returns on U.S. technology and infrastructure investments should embed a 2–4 percent illiquidity and regulatory-friction premium relative to unrestricted sectors. Second, global diversification mandates should explicitly account for asymmetric treatment: foreign investors often face tighter review than U.S. investors in equivalent sectors. Third, portfolio construction should distinguish between sectors with permanent CFIUS risk—semiconductors, energy infrastructure, certain biotech—and those with episodic risk.
Long-term allocators with 20+ year horizons face a distinct question: does the reduction in cross-border capital mobility justify geographic concentration, or do structural returns in restricted sectors justify the regulatory friction costs? This calculus varies by investor type and return requirements, but it is no longer ancillary to asset allocation. CFIUS is now a primary constraint, not a secondary compliance check.